Sera Prognostics, INC Form 4 insider transactions

Joshua Phillips, a Director of Sera Prognostics, Inc., reported multiple transactions in common stock on July 10, 2026.

Mansoor Raza Mirza, a Director of Sera Prognostics, Inc., reported multiple transactions in common stock on July 10, 2026.

Sandra Aj Lawrence, a Director of Sera Prognostics, Inc., reported multiple transactions in common stock on July 10, 2026.

Kim P. Kamdar, a Director of Sera Prognostics, Inc., reported multiple transactions in common stock on July 10, 2026.

Gregory C Critchfield, a Director of Sera Prognostics, Inc., reported multiple transactions in common stock on July 10, 2026.

Mark Christopher Capone, a Director of Sera Prognostics, Inc., reported multiple transactions in common stock on July 10, 2026.

Jane F Barlow, a Director of Sera Prognostics, Inc., reported multiple transactions in common stock on July 10, 2026.

Dyaarl Lee Anderson Jr., Chief Commercial Officer of SERA PROGNOSTICS, INC., sold 4,739 shares of Class A Common Stock to cover tax withholding obligations related to vesting restricted stock units.

Sera Prognostics CFO Austin Aerts sold 2,037 shares of common stock to cover tax withholding obligations related to vesting RSUs.

Sera Prognostics CEO Zhenya Lindgardt sold 6,990 shares of Class A Common Stock to cover tax withholding obligations related to RSU vesting.

Tiffany Inglis, Chief Medical Officer of Sera Prognostics, Inc., sold 362 shares of Class A Common Stock to cover tax withholding obligations related to vested restricted stock units.

Sera Prognostics reports a transaction where General Counsel Benjamin Jackson sold shares to cover tax withholding obligations related to vested RSUs.

Sera Prognostics CEO Zhenya Lindgardt sold 20,755 shares to cover tax withholding obligations upon RSU vesting, a non-discretionary transaction.

Austin Aerts, Chief Financial Officer of SERA PROGNOSTICS, INC., reported a transaction involving the sale of 5,440 shares of Class A Common Stock.

Director Sandra AJ Lawrence reported a sale of 1,560 shares of Class A Common Stock in SERA Prognostics, Inc. under a pre-established 10b5-1 trading plan.

Jeffrey Thomas Elliott will no longer serve as a director for Sera Prognostics, Inc. following the 2026 Annual Meeting of Stockholders.

General Counsel Benjamin Jackson acquired 5,000 shares of Sera Prognostics, Inc. common stock through the company's Employee Stock Purchase Plan.

Chief Commercial Officer Dyaarl Lee Anderson Jr. acquired 3,168 shares of Sera Prognostics common stock through the company's Employee Stock Purchase Plan.

Paul Kearney is no longer Sera Prognostics' Chief Data Officer as of March 12, 2026.

Robert Gardner is no longer Sera Prognostics' Chief Information Officer as of March 12, 2026.

SERA Prognostics CEO Zhenya Lindgardt was granted 154,440 restricted stock units and 239,442 stock options, aligning her interests with shareholders.

SERA Prognostics' General Counsel, Benjamin Jackson, acquired 44,215 restricted stock units and 68,550 stock options as part of his compensation.

SERA Prognostics' Chief Medical Officer, Tiffany Eul Davis Inglis, acquired 17,437 restricted stock units and 27,034 stock options on March 12, 2026.

Sera Prognostics' Chief Commercial Officer, Dyaarl Lee Anderson Jr., was granted restricted stock units and stock options as part of his compensation.

SERA Prognostics CFO Austin Aerts received grants of 44,215 restricted stock units and 68,550 stock options with multi-year vesting schedules.

SERA PROGNOSTICS, INC. CEO Zhenya Lindgardt sold shares of Class A Common Stock to cover tax withholding obligations related to RSU vesting.

Sera Prognostics' Chief Data Officer, Paul Kearney, sold 1,396 shares of Class A Common Stock to cover tax withholding obligations related to RSU vesting.

SERA Prognostics General Counsel Benjamin Jackson sold 1,027 shares of Class A Common Stock at a weighted average price of $2.04 to cover tax withholding obligations related to RSU vesting.

SERA PROGNOSTICS' Chief Information Officer, Robert Gardner Harrison, sold 716 shares of Class A Common Stock to cover tax withholding obligations related to restricted stock unit vesting.

SERA PROGNOSTICS' Chief Scientific Officer, John J. Boniface, sold 1,517 shares of Class A Common Stock to cover tax withholding obligations from RSU vesting.